NCT02654002View on ClinicalTrials.gov

Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674 (Cilofexor), and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 20, 2016

Primary Completion Date

July 14, 2016

Study Completion Date

July 14, 2016

Conditions
Nonalcoholic Steatohepatitis (NASH)
Interventions
DRUG

Cilofexor

Tablets administered orally

DRUG

Placebo

Tablets administered orally

Trial Locations (1)

Unknown

SeaView Research, Inc, Miami

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY